UK Investing $15.1M into New Synthetic Biology Center | GenomeWeb

NEW YORK (GenomeWeb News) – The UK is investing £10 million ($15.1 million) to create a new center to drive the translation of synthetic biology research into industrial applications.

The new Innovation and Knowledge Center (IKC) called SynbiCite announced today will be based at Imperial College London. Richard Kitney and Paul Freemont, professors at the university, will head the center, whose goal is to act as an industrial translation engine "that can integrate university and industry-based research in synthetic biology into industrial process and products."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.